Following post-doctoral research at the University of Sheffield and Royal Holloway, University of London, Amanda joined Brunel in 2006 to further develop her research interests in breast cancer.
Her research focuses on cell signalling pathways and their roles in mediating tumour-like behaviour, as well as their contribution to therapeutic drug resistance. Current projects are involve investigating the roles of breast tumour kinase (Brk) in cell responses to chemo- and radio-therapy, understanding the mechanisms behind everolimus resistance, and the part that 1q genes/proteins such as ACBD3 and PI4K play in breast cancer cell biology. In addition, she has research interests in the potential of plant extracts as novel anti-tumour agents.
Amanda has served on the Breast Cancer Campaign Scientific Advisory Board, and joined the British Association for Cancer Research (BACR) Executive Committee in 2016 becoming Treasurer in 2017.
BACR is a registered charity in England and Wales (289297)
c/o Leeds Institute of Medical Research at St James’s, Cancer Genetics Building,
St James's University Hospital, Beckett Street, Leeds LS9 7TF